TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2289936
log Bayes Factor = 0.0676215
Chromosome 12   position 65,471,467  (GRCh37) Explore rs2289936 on Ensembl!
Variant rs2289936 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C18 Malignant neoplasm of colon
0.212 0.788 0.000
C18.9 Colon, unspecified
0.205 0.795 0.000
C18.7 Sigmoid colon
0.200 0.800 0.000
C15-C26 Malignant neoplasms of digestive organs
0.197 0.803 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.187 0.813 0.000
C18.3 Hepatic flexure
0.183 0.817 0.000
C18.6 Descending colon
0.180 0.820 0.000
C15 Malignant neoplasm of oesophagus
0.177 0.823 0.000
C22.1 Intrahepatic bile duct carcinoma
0.176 0.824 0.000
C17 Malignant neoplasm of small intestine
0.173 0.827 0.000
C22.9 Liver, unspecified
0.162 0.838 0.000
C18.0 Caecum
0.161 0.839 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.158 0.842 0.000
C23 Malignant neoplasm of gallbladder
0.156 0.844 0.000
C18.5 Splenic flexure
0.156 0.844 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.153 0.847 0.000
C18.8 Overlapping lesion of colon
0.152 0.848 0.000
C18.1 Appendix
0.152 0.848 0.000
C16 Malignant neoplasm of stomach
0.152 0.848 0.000
C18.4 Transverse colon
0.151 0.849 0.000
C17.0 Duodenum
0.148 0.852 0.000
C15.3 Upper third of oesophagus
0.147 0.853 0.000
C15.5 Lower third of oesophagus
0.143 0.857 0.000
C15.4 Middle third of oesophagus
0.138 0.862 0.000
C18.2 Ascending colon
0.138 0.862 0.000
C22.7 Other specified carcinomas of liver
0.134 0.865 0.000
C22.4 Other sarcomas of liver
0.134 0.865 0.000
C22.3 Angiosarcoma of liver
0.134 0.865 0.000
C22.2 Hepatoblastoma
0.134 0.865 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.134 0.866 0.000
C17.2 Ileum
0.134 0.866 0.000
C21 Malignant neoplasm of anus and anal canal
0.132 0.868 0.000
C15.9 Oesophagus, unspecified
0.131 0.869 0.000
C17.9 Small intestine, unspecified
0.130 0.870 0.000
C15.8 Overlapping lesion of oesophagus
0.127 0.873 0.000
C15.2 Abdominal part of oesophagus
0.127 0.873 0.000
C15.1 Thoracic part of oesophagus
0.127 0.873 0.000
C15.0 Cervical part of oesophagus
0.127 0.873 0.000
C17.8 Overlapping lesion of small intestine
0.124 0.876 0.000
C17.3 Meckel's diverticulum
0.124 0.876 0.000
C17.1 Jejunum
0.124 0.876 0.000
C16.0 Cardia
0.119 0.881 0.000
C16.3 Pyloric antrum
0.119 0.881 0.000
C24.1 Ampulla of Vater
0.118 0.882 0.000
C22.0 Liver cell carcinoma
0.117 0.883 0.000
C24.0 Extrahepatic bile duct
0.113 0.887 0.000
C24.9 Biliary tract, unspecified
0.110 0.890 0.000
C24.8 Overlapping lesion of biliary tract
0.110 0.890 0.000
C16.8 Overlapping lesion of stomach
0.109 0.891 0.000
C16.6 Greater curvature of stomach, unspecified
0.109 0.891 0.000
C16.5 Lesser curvature of stomach, unspecified
0.109 0.891 0.000
C16.4 Pylorus
0.109 0.891 0.000
C16.2 Body of stomach
0.109 0.891 0.000
C16.1 Fundus of stomach
0.109 0.891 0.000
C26.9 Ill-defined sites within the digestive system
0.105 0.895 0.000
C25 Malignant neoplasm of pancreas
0.105 0.895 0.000
C21.1 Anal canal
0.097 0.903 0.000
C16.9 Stomach, unspecified
0.097 0.903 0.000
C26.8 Overlapping lesion of digestive system
0.096 0.904 0.000
C26.1 Spleen
0.096 0.904 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.095 0.905 0.000
C21.2 Cloacogenic zone
0.095 0.905 0.000
C21.0 Anus, unspecified
0.082 0.918 0.000
C25.8 Overlapping lesion of pancreas
0.075 0.925 0.000
C25.7 Other parts of pancreas
0.075 0.925 0.000
C25.4 Endocrine pancreas
0.075 0.925 0.000
C25.3 Pancreatic duct
0.075 0.925 0.000
C25.2 Tail of pancreas
0.075 0.925 0.000
C25.1 Body of pancreas
0.075 0.925 0.000
C26.0 Intestinal tract, part unspecified
0.074 0.926 0.000
C20 Malignant neoplasm of rectum
0.072 0.928 0.000
C25.9 Pancreas, unspecified
0.061 0.938 0.000
C25.0 Head of pancreas
0.059 0.940 0.000
M81.99 Osteoporosis, unspecified (Site unspecified)
0.000 0.983 0.017
T39.1 4-Aminophenol derivatives
0.000 0.988 0.012
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.992 0.008
M81.9 Osteoporosis, unspecified
0.000 0.992 0.007
M81.98 Osteoporosis, unspecified (Other)
0.000 0.993 0.007
C90.0 Multiple myeloma
0.006 0.994 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.994 0.006
C84 Peripheral and cutaneous T-cell lymphomas
0.006 0.994 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.994 0.006
C90 Multiple myeloma and malignant plasma cell neoplasms
0.006 0.994 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.006 0.994 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.994 0.006
C56 Malignant neoplasm of ovary
0.006 0.994 0.000
Chapter II Neoplasms
0.006 0.994 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.994 0.006
T39.4 Antirheumatics, not elsewhere classified
0.000 0.994 0.006
T39.2 Pyrazolone derivatives
0.000 0.994 0.006
M81.97 Osteoporosis, unspecified (Ankle and foot)
0.000 0.994 0.005
M81.96 Osteoporosis, unspecified (Lower leg)
0.000 0.994 0.005
M81.94 Osteoporosis, unspecified (Hand)
0.000 0.994 0.005
M81.93 Osteoporosis, unspecified (Forearm)
0.000 0.994 0.005
M81.92 Osteoporosis, unspecified (Upper arm)
0.000 0.994 0.005
M81.91 Osteoporosis, unspecified (Shoulder region)
0.000 0.994 0.005
C84.5 Other and unspecified T-cell lymphomas
0.006 0.994 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.994 0.006
C84.0 Mycosis fungoides
0.006 0.994 0.000
C81 Hodgkin's disease
0.006 0.994 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.994 0.006
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.994 0.006
H04.5 Stenosis and insufficiency of lachrymal passages
0.000 0.994 0.006
C81.9 Hodgkin's disease, unspecified
0.005 0.994 0.000
T39.0 Salicylates
0.000 0.994 0.005
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.005 0.995 0.000
T40.2 Other opioids
0.000 0.995 0.005
C91 Lymphoid leukaemia
0.005 0.995 0.000
C84.4 Peripheral T-cell lymphoma
0.005 0.995 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.995 0.005
C71 Malignant neoplasm of brain
0.005 0.995 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.995 0.005
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)
0.000 0.995 0.005
C51-C58 Malignant neoplasms of female genital organs
0.005 0.995 0.000
C91.1 Chronic lymphocytic leukaemia
0.005 0.995 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.005 0.995 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.005 0.995 0.000
C90.2 Plasmacytoma, extramedullary
0.005 0.995 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.995 0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.995 0.005
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.995 0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.995 0.005
T36 Poisoning by systemic antibiotics
0.000 0.995 0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.995 0.005
C84.9 Mature T/NK-cell lymphoma, unspecified
0.005 0.995 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.005 0.995 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.005 0.995 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.005 0.995 0.000
C84.3 Lymphoepithelioid lymphoma
0.005 0.995 0.000
C84.2 T-zone lymphoma
0.005 0.995 0.000
C84.1 Sezary's diease
0.005 0.995 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.995 0.005
C43.5 Malignant melanoma of trunk
0.005 0.995 0.000
T43.2 Other and unspecified antidepressants
0.000 0.995 0.005
C90.3 Solitary plasmacytoma
0.005 0.995 0.000
C90.1 Plasma cell leukaemia
0.005 0.995 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.995 0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.995 0.005
C71.1 Frontal lobe
0.005 0.995 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.005 0.995 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.995 0.000
C95 Leukaemia of unspecified cell type
0.004 0.995 0.000
C94 Other leukaemias of specified cell type
0.004 0.995 0.000
C93 Monocytic leukaemia
0.004 0.995 0.000
C86 Other specified types of T/NK-cell lymphoma
0.004 0.995 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.995 0.004
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.995 0.004
C71.8 Overlapping lesion of brain
0.004 0.995 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.995 0.004
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.995 0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.995 0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.996 0.004
C40-C41 Malignant neoplasms of bone and articular cartilage
0.004 0.996 0.000
C48.2 Peritoneum, unspecified
0.004 0.996 0.000
C69 Malignant neoplasm of eye and adnexa
0.004 0.996 0.000
T40.6 Other and unspecified narcotics
0.000 0.996 0.004
C81.7 Other Hodgkin's disease
0.004 0.996 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.004 0.996 0.000
C81.3 Lymphocytic depletion
0.004 0.996 0.000
C81.2 Mixed cellularity
0.004 0.996 0.000
C81.0 Lymphocytic predominance
0.004 0.996 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.996 0.004
T40.8 Lysergide [LSD]
0.000 0.996 0.004
T40.7 Cannabis (derivatives)
0.000 0.996 0.004
T40.5 Cocaine
0.000 0.996 0.004
T40.3 Methadone
0.000 0.996 0.004
T40.1 Heroin
0.000 0.996 0.004
T40.0 Opium
0.000 0.996 0.004
T50.8 Diagnostic agents
0.000 0.996 0.004
T50.7 Analeptics and opioid receptor antagonists
0.000 0.996 0.004
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.996 0.004
T50.5 Appetite depressants
0.000 0.996 0.004
T50.4 Drugs affecting uric acid metabolism
0.000 0.996 0.004
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.996 0.004
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.996 0.004
T50.1 Loop [high-ceiling] diuretics
0.000 0.996 0.004
T50.0 Mineralocorticoids and their antagonists
0.000 0.996 0.004
C88 Malignant immunoproliferative diseases
0.004 0.996 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.996 0.004
C97 Malignant neoplasms of independent (primary) multiple sites
0.004 0.996 0.000
C81.1 Nodular sclerosis
0.004 0.996 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.996 0.004
C49 Malignant neoplasm of other connective and soft tissue
0.004 0.996 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.004 0.996 0.000
C70 Malignant neoplasm of meninges
0.004 0.996 0.000
H26.8 Other specified cataract
0.004 0.996 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.996 0.004
C43-C44 Melanoma and other malignant neoplasms of skin
0.004 0.996 0.000
T40.4 Other synthetic narcotics
0.000 0.996 0.004
C71.3 Parietal lobe
0.004 0.996 0.000
C43 Malignant melanoma of skin
0.004 0.996 0.000
C91.9 Lymphoid leukaemia, unspecified
0.004 0.996 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.004 0.996 0.000
C91.7 Other lymphoid leukaemia
0.004 0.996 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.004 0.996 0.000
C91.5 Adult T-cell leukaemia
0.004 0.996 0.000
C91.4 Hairy-cell leukaemia
0.004 0.996 0.000
C91.3 Prolymphocytic leukaemia
0.004 0.996 0.000
C91.2 Subacute lymphocytic leukaemia
0.004 0.996 0.000
C71.7 Brain stem
0.004 0.996 0.000
C71.6 Cerebellum
0.004 0.996 0.000
C71.5 Cerebral ventricle
0.004 0.996 0.000
C71.4 Occipital lobe
0.004 0.996 0.000
C71.0 Cerebrum, except lobes and ventricles
0.004 0.996 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.996 0.004
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.996 0.004
T38.7 Androgens and anabolic congeners
0.000 0.996 0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.996 0.004
T38.5 Other oestrogens and progestogens
0.000 0.996 0.004
T38.4 Oral contraceptives
0.000 0.996 0.004
T38.2 Antithyroid drugs
0.000 0.996 0.004
T38.1 Thyroid hormones and substitutes
0.000 0.996 0.004
T38.0 Glucocorticoids and synthetic analogues
0.000 0.996 0.004
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.004 0.996 0.000
C71.9 Brain, unspecified
0.004 0.996 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.996 0.004
C57 Malignant neoplasm of other and unspecified female genital organs
0.004 0.996 0.000
C58 Malignant neoplasm of placenta
0.004 0.996 0.000
C52 Malignant neoplasm of vagina
0.004 0.996 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.004 0.996 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.004 0.996 0.000
C46 Kaposi's sarcoma
0.004 0.996 0.000
C71.2 Temporal lobe
0.004 0.996 0.000
C91.0 Acute lymphoblastic leukaemia
0.004 0.996 0.000
K66.0 Peritoneal adhesions
0.004 0.996 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
T36.0 Penicillins
0.000 0.996 0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.996 0.004
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.996 0.004
T37.5 Antiviral drugs
0.000 0.996 0.004
T37.4 Anthelminthics
0.000 0.996 0.004
T37.3 Other antiprotozoal drugs
0.000 0.996 0.004
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.996 0.004
T37.1 Antimycobacterial drugs
0.000 0.996 0.004
T37.0 Sulphonamides
0.000 0.996 0.004
T41.5 Therapeutic gases
0.000 0.996 0.004
T41.4 Anaesthetic, unspecified
0.000 0.996 0.004
T41.3 Local anaesthetics
0.000 0.996 0.004
T41.2 Other and unspecified general anaesthetics
0.000 0.996 0.004
T41.1 Intravenous anaesthetics
0.000 0.996 0.004
T41.0 Inhaled anaesthetics
0.000 0.996 0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.996 0.004
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.996 0.004
T48.5 Anti-common-cold drugs
0.000 0.996 0.004
T48.4 Expectorants
0.000 0.996 0.004
T48.3 Antitussives
0.000 0.996 0.004
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.996 0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
T48.0 Oxytocic drugs
0.000 0.996 0.004
T49.9 Topical agent, unspecified
0.000 0.996 0.004
T49.8 Other topical agents
0.000 0.996 0.004
T49.7 Dental drugs, topically applied
0.000 0.996 0.004
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.996 0.004
T49.5 Ophthalmological drugs and preparations
0.000 0.996 0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.996 0.004
T49.3 Emollients, demulcents and protectants
0.000 0.996 0.004
T49.2 Local astringents and local detergents
0.000 0.996 0.004
T49.1 Antipruritics
0.000 0.996 0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.996 0.004
T43.6 Psychostimulants with abuse potential
0.000 0.996 0.003
M81.90 Osteoporosis, unspecified (Multiple sites)
0.000 0.996 0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.996 0.003
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.996 0.003
T47.7 Emetics
0.000 0.996 0.003
T47.6 Antidiarrhoeal drugs
0.000 0.996 0.003
T47.5 Digestants
0.000 0.996 0.003
T47.4 Other laxatives
0.000 0.996 0.003
T47.3 Saline and osmotic laxatives
0.000 0.996 0.003
T47.2 Stimulant laxatives
0.000 0.996 0.003
T47.0 Histamine H(2)-receptor antagonists
0.000 0.996 0.003
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.003 0.996 0.001
C49.1 Connective and soft tissue of upper limb, including shoulder
0.004 0.996 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.996 0.003
T45.8 Other primarily systemic and haematological agents
0.000 0.996 0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.996 0.003
T45.6 Fibrinolysis-affecting drugs
0.000 0.996 0.003
T45.5 Anticoagulants
0.000 0.996 0.003
T45.4 Iron and its compounds
0.000 0.996 0.003
T45.3 Enzymes, not elsewhere classified
0.000 0.996 0.003
T45.2 Vitamins, not elsewhere classified
0.000 0.996 0.003
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.003
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.996 0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.996 0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.996 0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.996 0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.996 0.003
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.996 0.003
T44.0 Anticholinesterase agents
0.000 0.996 0.003
C55 Malignant neoplasm of uterus, part unspecified
0.004 0.996 0.000
C51 Malignant neoplasm of vulva
0.003 0.996 0.000
C92 Myeloid leukaemia
0.003 0.996 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.003 0.996 0.000
C48.1 Specified parts of peritoneum
0.003 0.996 0.000
C48.0 Retroperitoneum
0.003 0.996 0.000
C69.3 Choroid
0.003 0.996 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.003 0.996 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.003 0.996 0.000
C86.4 Blastic NK-cell lymphoma
0.003 0.996 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.003 0.996 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.003 0.996 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.003 0.996 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.003 0.996 0.000
C93.9 Monocytic leukaemia, unspecified
0.003 0.996 0.000
C93.7 Other monocytic leukaemia
0.003 0.996 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.003 0.996 0.000
C93.2 Subacute monocytic leukaemia
0.003 0.996 0.000
C93.1 Chronic monocytic leukaemia
0.003 0.996 0.000
C93.0 Acute monocytic leukaemia
0.003 0.996 0.000
C94.7 Other specified leukaemias
0.003 0.996 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.003 0.996 0.000
C94.5 Acute myelofibrosis
0.003 0.996 0.000
C94.4 Acute panmyelosis
0.003 0.996 0.000
C94.3 Mast cell leukaemia
0.003 0.996 0.000
C94.2 Acute megakaryoblastic leukaemia
0.003 0.996 0.000
C94.1 Chronic erythraemia
0.003 0.996 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.003 0.996 0.000
C95.9 Leukaemia, unspecified
0.003 0.996 0.000
C95.7 Other leukaemia of unspecified cell type
0.003 0.996 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.003 0.996 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.003 0.996 0.000
C95.0 Acute leukaemia of unspecified cell type
0.003 0.996 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.003 0.996 0.000
C96.8 Histiocytic sarcoma
0.003 0.996 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.003 0.996 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.003 0.996 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.003 0.996 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.003 0.996 0.000
C96.3 True histiocytic lymphoma
0.003 0.996 0.000
C96.2 Malignant mast cell tumour
0.003 0.996 0.000
C96.1 Malignant histiocytosis
0.003 0.996 0.000
C96.0 Letterer-Siwe disease
0.003 0.996 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.996 0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.996 0.003
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.996 0.003
T46.7 Peripheral vasodilators
0.000 0.996 0.003
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.996 0.003
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.996 0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.996 0.003
T46.1 Calcium-channel blockers
0.000 0.996 0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.996 0.003
X49.9 Unspecified place
0.004 0.996 0.000
C50-C50 Malignant neoplasm of breast
0.004 0.996 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.996 0.003
C43.9 Malignant melanoma of skin, unspecified
0.003 0.997 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.997 0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.997 0.003
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.997 0.003
T42.3 Barbiturates
0.000 0.997 0.003
T42.2 Succinimides and oxazolidinediones
0.000 0.997 0.003
T42.0 Hydantoin derivatives
0.000 0.997 0.003
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.003 0.997 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.003 0.997 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.003 0.997 0.000
S42.20 Fracture of upper end of humerus (closed)
0.003 0.997 0.000
C03 Malignant neoplasm of gum
0.003 0.997 0.000
C50.1 Central portion of breast
0.003 0.997 0.000
K50.9 Crohn's disease, unspecified
0.003 0.997 0.000
C69.9 Eye, unspecified
0.003 0.997 0.000
C69.8 Overlapping lesion of eye and adnexa
0.003 0.997 0.000
C69.6 Orbit
0.003 0.997 0.000
C69.5 Lachrymal gland and duct
0.003 0.997 0.000
C69.4 Ciliary body
0.003 0.997 0.000
C69.2 Retina
0.003 0.997 0.000
C69.1 Cornea
0.003 0.997 0.000
C69.0 Conjunctiva
0.003 0.997 0.000
D00-D09 In situ neoplasms
0.003 0.997 0.000
C78.2 Secondary malignant neoplasm of pleura
0.003 0.997 0.000
C53 Malignant neoplasm of cervix uteri
0.003 0.997 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.003 0.997 0.000
C88.7 Other malignant immunoproliferative diseases
0.003 0.997 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.003 0.997 0.000
C88.3 Immunoproliferative small intestinal disease
0.003 0.997 0.000
C88.2 Gamma heavy chain disease
0.003 0.997 0.000
C88.1 Alpha heavy chain disease
0.003 0.997 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.003 0.997 0.000
D09.0 Bladder
0.003 0.997 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.997 0.003
D09 Carcinoma in situ of other and unspecified sites
0.003 0.997 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.003 0.997 0.000
Z51.0 Radiotherapy session
0.000 0.997 0.003
C49.9 Connective and soft tissue, unspecified
0.003 0.997 0.000
C49.8 Overlapping lesion of connective and soft tissue
0.003 0.997 0.000
C49.6 Connective and soft tissue of trunk, unspecified
0.003 0.997 0.000
C49.5 Connective and soft tissue of pelvis
0.003 0.997 0.000
C49.4 Connective and soft tissue of abdomen
0.003 0.997 0.000
C49.3 Connective and soft tissue of thorax
0.003 0.997 0.000
C49.0 Connective and soft tissue of head, face and neck
0.003 0.997 0.000
C04 Malignant neoplasm of floor of mouth
0.003 0.997 0.000
C70.9 Meninges, unspecified
0.003 0.997 0.000
C70.1 Spinal meninges
0.003 0.997 0.000
C70.0 Cerebral meninges
0.003 0.997 0.000
C72.9 Central nervous system, unspecified
0.003 0.997 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.003 0.997 0.000
C72.5 Other and unspecified cranial nerves
0.003 0.997 0.000
C72.4 Acoustic nerve
0.003 0.997 0.000
C72.3 Optic nerve
0.003 0.997 0.000
C72.2 Olfactory nerve
0.003 0.997 0.000
C72.1 Cauda equina
0.003 0.997 0.000
C72.0 Spinal cord
0.003 0.997 0.000
C43.4 Malignant melanoma of scalp and neck
0.003 0.997 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.003 0.997 0.000
C43.8 Overlapping malignant melanoma of skin
0.003 0.997 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.003 0.997 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.003 0.997 0.000
C43.0 Malignant melanoma of lip
0.003 0.997 0.000
C82.0 Small cleaved cell, follicular
0.003 0.997 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.003 0.997 0.000
C13 Malignant neoplasm of hypopharynx
0.003 0.997 0.000
C11 Malignant neoplasm of nasopharynx
0.003 0.997 0.000
C10 Malignant neoplasm of oropharynx
0.003 0.997 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.003 0.997 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.003 0.997 0.000
C05 Malignant neoplasm of palate
0.003 0.997 0.000
C00 Malignant neoplasm of lip
0.003 0.997 0.000
C12 Malignant neoplasm of pyriform sinus
0.003 0.997 0.000
C07 Malignant neoplasm of parotid gland
0.003 0.997 0.000
T42.1 Iminostilbenes
0.000 0.997 0.003
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.003 0.997 0.000
S82.60 Fracture of lateral malleolus (closed)
0.000 0.997 0.003
C43.7 Malignant melanoma of lower limb, including hip
0.003 0.997 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.003 0.997 0.000
F01.9 Vascular dementia, unspecified
0.000 0.997 0.003
C03.1 Lower gum
0.003 0.997 0.000
C57.9 Female genital organ, unspecified
0.003 0.997 0.000
C57.8 Overlapping lesion of female genital organs
0.003 0.997 0.000
C57.7 Other specified female genital organs
0.003 0.997 0.000
C57.4 Uterine adnexa, unspecified
0.003 0.997 0.000
C57.3 Parametrium
0.003 0.997 0.000
C57.2 Round ligament
0.003 0.997 0.000
C57.1 Broad ligament
0.003 0.997 0.000
C57.0 Fallopian tube
0.003 0.997 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.003 0.997 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.003 0.997 0.000
C82.6 Cutaneous follicle centre lymphoma
0.003 0.997 0.000
C82.5 Diffuse follicle centre lymphoma
0.003 0.997 0.000
C82.4 Follicular lymphoma grade IIIb
0.003 0.997 0.000
C82.3 Follicular lymphoma grade IIIa
0.003 0.997 0.000
C82.2 Large cell, follicular
0.003 0.997 0.000
H66.3 Other chronic suppurative otitis media
0.000 0.997 0.003
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.003 0.997 0.000
C46.9 Kaposi's sarcoma, unspecified
0.003 0.997 0.000
C46.8 Kaposi's sarcoma of multiple organs
0.003 0.997 0.000
C46.7 Kaposi's sarcoma of other sites
0.003 0.997 0.000
C46.3 Kaposi's sarcoma of lymph nodes
0.003 0.997 0.000
C46.2 Kaposi's sarcoma of palate
0.003 0.997 0.000
C46.1 Kaposi's sarcoma of soft tissue
0.003 0.997 0.000
C46.0 Kaposi's sarcoma of skin
0.003 0.997 0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.003 0.997 0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.003 0.997 0.000
C47.6 Peripheral nerves of trunk, unspecified
0.003 0.997 0.000
C47.5 Peripheral nerves of pelvis
0.003 0.997 0.000
C47.4 Peripheral nerves of abdomen
0.003 0.997 0.000
C47.3 Peripheral nerves of thorax
0.003 0.997 0.000
C47.2 Peripheral nerves of lower limb, including hip
0.003 0.997 0.000
C47.1 Peripheral nerves of upper limb, including shoulder
0.003 0.997 0.000
C47.0 Peripheral nerves of head, face and neck
0.003 0.997 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.003 0.997 0.000
C79.6 Secondary malignant neoplasm of ovary
0.003 0.997 0.000
C64-C68 Malignant neoplasms of urinary tract
0.003 0.997 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.002 0.997 0.001
C74 Malignant neoplasm of adrenal gland
0.002 0.997 0.001
C78.1 Secondary malignant neoplasm of mediastinum
0.003 0.997 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.003 0.997 0.000
C51.8 Overlapping lesion of vulva
0.003 0.997 0.000
C51.2 Clitoris
0.003 0.997 0.000
C51.1 Labium minus
0.003 0.997 0.000
C51.0 Labium majus
0.003 0.997 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.003 0.997 0.000
C45 Mesothelioma
0.003 0.997 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.003 0.997 0.000
S92.00 Fracture of calcaneus (closed)
0.003 0.997 0.000
C92.9 Myeloid leukaemia, unspecified
0.003 0.997 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.003 0.997 0.000
C92.7 Other myeloid leukaemia
0.003 0.997 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.003 0.997 0.000
C92.5 Acute myelomonocytic leukaemia
0.003 0.997 0.000
C92.4 Acute promyelocytic leukaemia
0.003 0.997 0.000
C92.3 Myeloid sarcoma
0.003 0.997 0.000
C92.2 Subacute myeloid leukaemia
0.003 0.997 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.003 0.997 0.000
C04.9 Floor of mouth, unspecified
0.003 0.997 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.003 0.997 0.000
T42.4 Benzodiazepines
0.000 0.997 0.003
C40.9 Bone and articular cartilage of limb, unspecified
0.002 0.997 0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs
0.002 0.997 0.000
C40.3 Short bones of lower limb
0.002 0.997 0.000
C40.2 Long bones of lower limb
0.002 0.997 0.000
C40.1 Short bones of upper limb
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.